Safety and Feasibility Assessment of the Bio-electrical One Day Capsule System in Overweight and Class I Obese Participants

Inclusion Criteria: 1. Age of 21-65 years old at time of screening 2. Body mass Index (BMI) \>= 27 and \<35 3. The subject has been under routine care of the investigator or another single physician that can supply a medical record for at least 4 months prior to enrollment 4. Female subjects at reproductive age that are tested negative for pregnancy 5. Women with childbearing potential (i.e., not post-menopausal or surgically sterilized) must agree to use adequate birth control methods during the whole study duration 6. No significant weight loss (\<5%) within four months prior to enrollment (by self -report) 7. No recorded or treated psychological disorder(s) for at least six months prior to enrollment (by self report) 8. Not taking anti-depressant medication, for at least six months prior to enrollment. 9. Willingness to refrain from using prescription, over the counter or herbal weight loss products for the duration of he trial. 10. Personally motivated and willing to comply with all the requirements of the clinical trial 11. Able to understand, read and voluntary sign the inform consent form 12. Agree and able to sign the consent form for the Pillcam(R) patency capsule test as is in use at Meir MC. Exclusion Criteria: 1. History o abdominal or gastrointestinal surgery (appendectomy, hernia repair, gynecological surgeries and cholecystectomy more than a year ago are allowed) 2. Prior bariatric surgery 3. Implanted electrical stimulation devices (e.g. pacemaker, defibrillator, neurostimulator) 4. Unwillingness to stop medication altering gastric pH and/or affecting GI motility during the entire study duration. 5. Known diagnosed psychiatric conditions that may impair subject's ability to comply with the study procedures (by self-report) 6. Use of anti-psychotic medications 7. Diagnosed with an eating disorder including bulimia and binge eating 8. Swallowing difficulties 9. Significant active or unstable acute or chronic illnesses/ diseases including gastrointestinal, systemic (non-gastrointestinal) and psychiatric conditions 10. Use of another investigation device or agent in the 30 days prior to enrollment 11. Women who are pregnant, lactating or anticipate to becoming pregnant within the study duration 12. Planned or contemplated use of Magnetic Resonance Imaging (MRI) or any (e.g. oncologic) radiation during the course of the trial. 13. Have a family member who is currently participating in this clinical trial 14. Any other conditions that, in the opinion of the investigator, would make the subject unsuitable for the study